Startseite Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer’s disease
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer’s disease

  • Agatha Grela

    Agatha Grela obtained her MSc at the Jagiellonian University, Krakow, in analytical chemistry (2010) and she is a PhD student there. Her master’s degree research was undertaken at the Laboratory of Analytical Toxicology and Monitored Therapy (Department of Toxicology and Environmental Diseases) at the Medical College of the Jagiellonian University. In 2010, she had a monthly internship in the Crime Lab of Criminal Intelligence Service Austria. Her prime interest is metabolomics in neuropsychiatric diseases, especially depression.

    , Agata Turek

    Agata Turek obtained her BSc at the Jagiellonian University, Krakow, in analytical chemistry (2011), where she is a master’s student. In 2011, she won a scholarship that enabled her to do a monthly internship at the Department of Forensic Medicine of the Medical University of Silesia in Katowice. Additionally to studying chemistry, she studies medical analytics at the Faculty of Pharmacy of the Jagiellonian University.

    und Wojciech Piekoszewski

    Wojciech Piekoszewski is a Professor of Medical Sciences with a second degree specialization in Toxicology. He is the Head of the Toxicological and Pharmaceutical Analysis Group in the Department of Analytical Chemistry and the Head of the Laboratory of High-Resolution Mass Spectrometry, Regional Laboratory of Physicochemical Analysis and Structural Research of the Faculty of Chemistry, Jagiellonian University, Krakow, Poland.

    He graduated and obtained his PhD and DSc at the Medical College of the Jagiellonian University. He spent 6 months at the Institute of Toxicology and Pharmacology at the University of Wurzburg, Germany, on postdoctoral fellowship, and 30 months as a visiting Professor at the Department of Pharmaceutical Sciences at the State University of New York at Buffalo.

    W. Piekoszewski’s scientific interests are in the application of metabolomics and lipidomics as tools for diagnosis of mental and neurodegenerative disorders, and analysis of drugs and medicaments in biological materials. He is a European Registered Toxicologist.

    To date he has authored over 100 scientific publications.

    EMAIL logo
Veröffentlicht/Copyright: 11. Februar 2012
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Alzheimer’s disease is becoming an increasing problem in our aging society. According to our knowledge, so far, no effective pharmacotherapy to cure the cause of the disease has been developed. Therefore, early diagnosis is needed, which will result in implementation of a drug therapy aimed at decreasing and/or inhibiting disease development. Mass spectrometry techniques (MS) have a wide range of applications in proteomics and the search for biomarkers of neurodegenerative disorders, opening new possibilities in diagnostics. Identification of proteins in body fluids (like cerebrospinal fluid or blood) is possible due to MS spectra analysis. The detected changes in protein concentrations are connected with pathological states in an organism and, therefore, can be regarded as biomarkers. Developing procedures for proteome analysis might result in fast diagnosis, as well as creating better suited pharmaceuticals. This paper reviews the search of biomarkers in cerebrospinal fluid and blood. Later on, the use of matrix-assisted-laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in proteomics, focusing on blood-related biomarkers, is discussed. The aim of the work is also to highlight the advantages and disadvantages of MALDI-TOF-based analyses.


Corresponding author: Wojciech Piekoszewski, PhD, DSc, Department of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University R. Ingardena 3 30-060 Krakow, Poland Phone: +(48 12) 663 56 00, Fax: +(48 12) 663 56 01

About the authors

Agatha Grela

Agatha Grela obtained her MSc at the Jagiellonian University, Krakow, in analytical chemistry (2010) and she is a PhD student there. Her master’s degree research was undertaken at the Laboratory of Analytical Toxicology and Monitored Therapy (Department of Toxicology and Environmental Diseases) at the Medical College of the Jagiellonian University. In 2010, she had a monthly internship in the Crime Lab of Criminal Intelligence Service Austria. Her prime interest is metabolomics in neuropsychiatric diseases, especially depression.

Agata Turek

Agata Turek obtained her BSc at the Jagiellonian University, Krakow, in analytical chemistry (2011), where she is a master’s student. In 2011, she won a scholarship that enabled her to do a monthly internship at the Department of Forensic Medicine of the Medical University of Silesia in Katowice. Additionally to studying chemistry, she studies medical analytics at the Faculty of Pharmacy of the Jagiellonian University.

Wojciech Piekoszewski

Wojciech Piekoszewski is a Professor of Medical Sciences with a second degree specialization in Toxicology. He is the Head of the Toxicological and Pharmaceutical Analysis Group in the Department of Analytical Chemistry and the Head of the Laboratory of High-Resolution Mass Spectrometry, Regional Laboratory of Physicochemical Analysis and Structural Research of the Faculty of Chemistry, Jagiellonian University, Krakow, Poland.

He graduated and obtained his PhD and DSc at the Medical College of the Jagiellonian University. He spent 6 months at the Institute of Toxicology and Pharmacology at the University of Wurzburg, Germany, on postdoctoral fellowship, and 30 months as a visiting Professor at the Department of Pharmaceutical Sciences at the State University of New York at Buffalo.

W. Piekoszewski’s scientific interests are in the application of metabolomics and lipidomics as tools for diagnosis of mental and neurodegenerative disorders, and analysis of drugs and medicaments in biological materials. He is a European Registered Toxicologist.

To date he has authored over 100 scientific publications.

Received: 2011-8-16
Accepted: 2012-1-10
Published Online: 2012-02-11
Published in Print: 2012-08-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact
  5. Reviews
  6. Mitochondria as sources and targets of damage in cellular aging
  7. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer’s disease
  8. Opinion Papers
  9. The intellectual contribution of laboratory medicine professionals to research papers on laboratory medicine topics published in high-impact general medicine journals
  10. Laboratory medicine and sports: between Scylla and Charybdis
  11. Guidelines and Recommendations
  12. The EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 4 – 2012
  13. Genetics And Molecular Diagnostics
  14. Assessing the utility of whole genome amplified DNA as a template for DMET Plus array
  15. General Clinical Chemistry And Laboratory Medicine
  16. Effect of acceleration forces during transport through a pneumatic tube system on ROTEM® analysis
  17. The transferrin/log(ferritin) ratio: a new tool for the diagnosis of iron deficiency anemia
  18. Instructions on laboratory monitoring in 200 drug labels
  19. Lipid peroxidation markers in Crohn’s disease: the associations and diagnostic value
  20. Impact of asthmatic control status on serum cystatin C concentrations
  21. Elevated levels of Nɛ-homocysteinyl-lysine isopeptide in patients on long-term hemodialysis
  22. Interleukin-1α gene variants influence bone mineral density and the risk of osteoporotic hip fractures in elderly Slovenian people
  23. Novel method to dissociate platelet clumps in EDTA-dependent pseudothrombocytopenia based on the pathophysiological mechanism
  24. Proficiency testing/external quality assurance for the PFA-100®
  25. Interference of selected flavonoid aglycons in platelet aggregation assays
  26. Infectious Diseases
  27. Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report
  28. Association between ischemia-modified albumin, homocysteine, vitamin B12 and folic acid in patients with severe sepsis
  29. Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects
  30. The predictive value of immature granulocyte count and immature myeloid information in the diagnosis of neonatal sepsis
  31. Hypophosphatemia, fever and prolonged length of hospital stay in seronegative PCR positive patients as compared to seropositive patients with early acute Q fever pneumonia
  32. Cancer Diagnostics
  33. Diagnostic value of HE4 for ovarian cancer: a meta-analysis
  34. Cardiovascular Diseases
  35. Reactive oxygen metabolites (ROMs) are associated with cardiovascular disease in chronic hemodialysis patients
  36. Methylenetetrahydrofolate reductase C677T and reduced folate carrier 80 G>A polymorphisms are associated with an increased risk of conotruncal heart defects
  37. Oxidative stress as a predictor of cardiovascular events in coronary artery disease patients
  38. Behavioral and clinical correlates of high-sensitivity C-reactive protein in Japanese men and women
  39. Letters to the Editor
  40. Hemoglobin Rambam has a constant retention time on the Tosoh G8 and interferes with the measurement of HbA1c
  41. Measurement of glycated hemoglobin in a patient with homozygous hemoglobin E
  42. Congress Abstracts
  43. 56th National Congress of the Hungarian Society of Laboratory Medicine
Heruntergeladen am 16.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0550/html
Button zum nach oben scrollen